U.S. RESEARCH ROUNDUP-Acuity Brands, CSG Systems International, Nuvation Bio

Acuity

27/03/2024 07:23

March 27 (Reuters) - Wall Street securities analysts revised their ratings and price
targets on several U.S.-listed companies, including Acuity Brands, CSG Systems International and
Nuvation Bio, on Wednesday.
    
  HIGHLIGHTS        
                 * Acuity Brands Inc  AYI.N : Baird raises target price to $286 from $236 
 
                 * CSG Systems International  CSGS.O : RBC initiates coverage with outperform rating 
 
                 * Lenz Therapeutics Inc  LENZ.O : Piper Sandler initiates coverage with overweight rating 
 
                 * Nuvation Bio Inc  NUVB.N : Jefferies raises to buy from hold
 
                 * Transdigm Group Inc  TDG.N : JP Morgan raises target price to $1,175 from $1,050 
 
 
Following is a summary of research actions on U.S. companies reported by Reuters on Wednesday.
Stock entries are in alphabetical order.  
    
                 * Acuity Brands Inc  AYI.N : Baird raises target price to $286 from $236 
 
                 * Acumen Pharmaceuticals Inc  ABOS.O : BTIG cuts target price to $11 from $22 
 
                 * Annexon Inc  ANNX.O : Jefferies raises target price to $10 from $8.5 
 
                 * Aprea Therapeutics Inc  APRE.O : Wedbush raises target price to $11 from $9 
 
                 * Arch Resources Inc  ARCH.N : Jefferies cuts target price to $185 from $190 
 
                 * Bluebird Bio Inc  BLUE.O : Raymond James cuts target price to $7 from $13 
 
                 * Bluebird Bio Inc  BLUE.O : Wedbush raises target price to $1.72 from $1.68 
 
                 * Celsius Holdings Inc  CELH.O : Jefferies raises target price to $107 from $105 
 
                 * CSG Systems International  CSGS.O : RBC initiates coverage with outperform rating 
 
                 * CSG Systems International  CSGS.O : RBC initiates target price $61 
 
                 * Dow Inc  DOW.N : Jefferies raises target price to $60 from $56 
 
                 * Getty Realty Corp  GTY.N : JP Morgan cuts target price to $31 from $32 
 
                 * Immunome Inc  IMNM.O : Leerink Partners cuts target price to $38 from $40 
 
                 * International Flavors & Fragrances  IFF.N : Morgan Stanley raises PT to $96 from $89 
 
                 * Korro Bio Inc  KRRO.O : RBC raises target price to $90 from $70 
 
                 * Lenz Therapeutics Inc  LENZ.O : Piper Sandler initiates coverage with overweight rating 
 
                 * Lenz Therapeutics Inc  LENZ.O : Piper Sandler initiates target price $28 
 
                 * Mastercard Inc  MA.N : Evercore ISI raises target price to $545 from $530 
 
                 * McCormick & Company Inc  MKC.N : Jefferies raises target price to $77 from $67
 
                 * McCormick & Company Inc  MKC.N : TD Cowen raises target price to $75 from $67 
 
                 * Merck & Co Inc  MRK.N : Jefferies raises target price to $145 from $140 
 
                 * Nexpoint Real Estate Finance Inc  NREF.N : Raymond James cuts PT to $17 from $19 
 
                 * Nuvation Bio Inc  NUVB.N : Jefferies raises to buy from hold
 
                 * Nuvation Bio Inc  NUVB.N : Jefferies raises target price to $10 from $1.4 
 
                 * Praxis Precision Medicines Inc  PRAX.O : Jefferies raises PT to $128 from $75
 
                 * Progress Software Corp  PRGS.O : JP Morgan cuts target price to $63 from $65 
 
                 * Realty Income Corp  O.N : JP Morgan cuts target price to $60 from $64 
 
                 * TD Synnex Corp  SNX.N : Raymond James raises target price to $125 from $120 
 
                 * TD Synnex Corp  SNX.N : RBC raises target price to $118 from $110 
 
                 * Third Harmonic Bio Inc  THRD.O : Jefferies raises target price to $8.1 from $3.6 
 
                 * Transdigm Group Inc  TDG.N : JP Morgan raises target price to $1,175 from $1,050 
 
                 * United Therapeutics Corp  UTHR.O : Leerink Partners raises PT to $335 from $330 
 
                 * UPS  UPS.N : Jefferies cuts target price to $175 from $180 
 
                 * Viking Therapeutics Inc  VKTX.O : Leerink Partners raises PT to $115 from $105 
 
                 * Viking Therapeutics Inc  VKTX.O : Oppenheimer raises target price to $138 from $116 
 
                 * Visa Inc  V.N : Evercore ISI raises target price to $335 from $325 
 
 
    

 (Compiled by Bengaluru Newsroom)
 ((Diaries@thomsonreuters.com))